(Q33332211)
Statements
Novel marine-derived anticancer agents: a phase I clinical, pharmacological, and pharmacodynamic study of dolastatin 10 (NSC 376128) in patients with advanced solid tumors (English)
Madden T
Tran HT
Beck D
Huie R
Newman RA
Pusztai L
Wright JJ